Department of Error (DOI:10.1016/S0140-6736(07)61634-1);Human atrial natriuretic peptide and nicorandil as adjuncts to reperfusion treatment for acute myocardial infarction (J-WIND): two randomised trials

Lancet

Volumn 370, Issue 9597, 2007, Pages 1483-1493

  Kitakaze, Masafumi ^a   Asakura, Masanori ^a   Kim, Jiyoong ^a   Shintani, Yasunori ^b   Asanuma, Hiroshi ^a   Hamasaki, Toshimitsu ^b   Seguchi, Osamu ^a   Myoishi, Masafumi ^a   Minamino, Tetsuo ^b   Ohara, Takahiro ^a   Nagai, Yoshiyuki ^c   Nanto, Shinsuke ^d   Watanabe, Kouki ^e   Fukuzawa, Shigeru ^f   Hirayama, Atsushi ^g   Nakamura, Natsuki ^h   Kimura, Kazuo ⁱ   Fujii, Kenshi ^j   Ishihara, Masaharu ^k   Saito, Yoshihiko ^l   Tomoike, Hitonobu ^a   Kitamura, Soichiro ^a   more..

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c Department of Cardiology   (Japan)

^d KANSAI ROSAI HOSPITAL   (Japan)

^e Uwajima City Hospital   (Japan)

^f Funabashi Municipal Medical Center   (Japan)

^g OSAKA POLICE HOSPITAL   (Japan)

^h Department of Radiology   (Japan)

ⁱ YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

^j Sakurabashi Watanabe Hospital   (Japan)

^k HIROSHIMA CITY HOSPITAL   (Japan)

^l NARA MEDICAL UNIVERSITY   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR; CREATINE KINASE; NICORANDIL; PLACEBO;

ACUTE DISEASE; ACUTE HEART INFARCTION; ADULT; AGED; ANGIOGRAPHY; ARTICLE; BOLUS INJECTION; BRAIN INFARCTION SIZE; CHRONIC DISEASE; CLINICAL ASSESSMENT; CLINICAL TRIAL; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DRUG EFFECT; ENZYME ACTIVITY; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITAL ADMISSION; HUMAN; HYPOTENSION; JAPAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REPERFUSION; REPERFUSION INJURY; SINGLE BLIND PROCEDURE; TREATMENT RESPONSE;

EID: 35448998412     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(07)61903-5     Document Type: Erratum

References (35)

1. Thom T., Haase N., Rosamond W., et al. Heart disease and stroke statistics-2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 113 (2006) 85-151
2. Jessup M., and Brozena S. Heart failure. N Engl J Med 348 (2003) 2007-2018
3. Levy D., Kenchaiah S., Larson M., et al. Long-term trends in the incidence of and survival with heart failure. N Engl J Med 347 (2002) 1397-1402
4. Shiba N., Watanabe J., Shinozaki T., et al. Poor prognosis of Japanese patients with chronic heart failure following myocardial infarction-comparison with nonischemic cardiomyopathy. Circ J 69 (2005) 143-149
5. Kloner R., and Rezkalla S. Cardiac protection during acute myocardial infarction: where do we stand in 2004?. J Am Coll Cardiol 44 (2004) 276-286
6. The MIAMI Trial Research Group. Metoprolol in acute myocardial infarction (MIAMI). A randomised placebo-controlled international trial. Eur Heart J 6 (1985) 199-226
7. Ross A., Gibbons R., Stone G., Kloner R., and Alexander R. A randomised, double-blinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMISTAD-II). J Am Coll Cardiol 45 (2005) 1775-1780
8. van der Horst I., Zijlstra F., van't Hof A., et al. Glucose-insulin-potassium infusion inpatients treated with primary angioplasty for acute myocardial infarction: the glucose-insulin-potassium study: a randomised trial. J Am Coll Cardiol 42 (2003) 784-791
9. Grines C., Browne K., Marco J., et al. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group. N Engl J Med 328 (1993) 673-679
10. Sakurai K., Watanabe J., Iwabuchi K., et al. Comparison of the efficacy of reperfusion therapies for early mortality from acute myocardial infarction in Japan: registry of Miyagi Study Group for AMI (MsAMI). Circ J 67 (2003) 209-214
11. Lamas G., Flaker G., Mitchell G., et al. Effect of infarct artery patency on prognosis after acute myocardial infarction. The Survival and Ventricular Enlargement Investigators. Circulation 92 (1995) 1101-1109
12. Verma S., Fedak P., Weisel R., et al. Fundamentals of reperfusion injury for the clinical cardiologist. Circulation 105 (2002) 2332-2336
13. Zeymer U., Suryapranata H., Monassier J., et al. The Na(+)/H(+) exchange inhibitor eniporide as an adjunct to early reperfusion therapy for acute myocardial infarction. Results of the evaluation of the safety and cardioprotective effects of eniporide in acute myocardial infarction (ESCAMI) trial. J Am Coll Cardiol 38 (2001) 1644-1650
14. European Study of Prevention of Infarct with Molsidomine (ESPRIM) Group. The ESPRIM trial: short-term treatment of acute myocardial infarction with molsidomine. Lancet 344 (1994) 91-97
15. Wall T., Califf R., Blankenship J., et al. Intravenous fluosol in the treatment of acute myocardial infarction. Results of the Thrombolysis and Angioplasty in Myocardial Infarction 9 Trial. TAMI 9 Research Group. Circulation 90 (1994) 114-120
16. Cody R., Atlas S., Laragh J., et al. Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion. J Clin Invest 78 (1986) 1362-1374
17. Emori T., Hirata Y., Imai T., Eguchi S., Kanno K., and Marumo F. Cellular mechanism of natriuretic peptides-induced inhibition of endothelin-1 biosynthesis in rat endothelial cells. Endocrinology 133 (1993) 2474-2480
18. Kitakaze M., Minamino T., Node K., et al. Role of activation of ectosolic 5′-nucleotidase in the cardioprotection mediated by opening of K+ channels. Am J Physiol 270 (1996) 1744-1756
19. Mizumura T., Nithipatikom K., and Gross G. Infarct size-reducing effect of nicorandil is mediated by the KATP channel but not by its nitrate-like properties in dogs. Cardiovasc Res 32 (1996) 274-285
20. Hayashi M., Tsutamoto T., Wada A., et al. Intravenous atrial natriuretic peptide prevents left ventricular remodeling in patients with first anterior acute myocardial infarction. J Am Coll Cardiol 37 (2001) 1820-1826
21. Kuga H., Ogawa K., Oida A., et al. Administration of atrial natriuretic peptide attenuates reperfusion phenomena and preserves left ventricular regional wall motion after direct coronary angioplasty for acute myocardial infarction. Circ J 67 (2003) 443-448
22. Sugimoto K., Ito H., Iwakura K., et al. Intravenous nicorandil in conjunction with coronary reperfusion therapy is associated with better clinical and functional outcomes in patients with acute myocardial infarction. Circ J 67 (2003) 295-300
23. Sakata Y., Kodama K., Komamura K., et al. Salutary effect of adjunctive intracoronary nicorandil administration on restoration of myocardial blood flow and functional improvement in patients with acute myocardial infarction. Am Heart J 133 (1997) 616-621
24. Fukuzawa S., Ozawa S., Inagaki M., et al. Nicorandil affords cardioprotection in patients with acute myocardial infarction treated with primary percutaneous transluminal coronary angioplasty: assessment with thallium-201/iodine-123 BMIPP dual SPECT. J Nucl Cardiol 7 (2000) 447-453
25. Ishii H., Ichimiya S., Kanashiro M., et al. Impact of a single intravenous administration of nicorandil before reperfusion in patients with ST-segment-elevation myocardial infarction. Circulation 112 (2005) 1284-1288
26. Asakura M., Jiyoong K., Minamino T., Shintani Y., Asanuma H., and Kitakaze M. Rationale and design of a large-scale trial using atrial natriuretic peptide (ANP) as an adjunct to percutaneous coronary intervention for ST-segment elevation acute myocardial infarction: Japan-Working groups of acute myocardial infarction for the reduction of Necrotic Damage by ANP (J-WIND-ANP). Circ J 68 (2004) 95-100
27. Minamino T., Jiyoong K., Asakura M., Shintani Y., Asanuma H., and Kitakaze M. Rationale and design of a large-scale trial using nicorandil as an adjunct to percutaneous coronary intervention for ST-segment elevation acute myocardial infarction: Japan-Working groups of acute myocardial infarction for the reduction of Necrotic Damage by a K-ATP channel opener (J-WIND-KATP). Circ J 68 (2004) 101-106
28. Seino Y., Tomita Y., Hoshino K., Setsuta K., Takano T., and Hayakawa H. Pathophysiological analysis of serum troponin T release kinetics in evolving ischemic myocardial injury. Jpn Circ J 60 (1996) 265-276
29. Steen H., Giannitsis E., Futterer S., Merten C., Juenger C., and Katus H. Cardiac troponin T at 96 hours after acute myocardial infarction correlates with infarct size and cardiac function. J Am Coll Cardiol 48 (2006) 2192-2194
30. Vollmer R., Christenson R., Reimer K., and Ohman E. Temporal creatine kinase curves in acute myocardial infarction. Implications of a good empiric fit with the log-normal function. Am J Clin Pathol 100 (1993) 293-298
31. Therneau T., and Grambsch P. Modeling survival data: extending the Cox model (2000), Springer, New York, USA
32. Hess K. Graphical methods for assessing violations of the proportional hazards assumption in Cox regression. Stat Med 14 (1995) 1707-1723
33. Mahaffey K., Puma J., Barbagelata N., et al. Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction: results of a multicenter, randomised, placebo-controlled trial: the Acute Myocardial Infarction STudy of ADenosine (AMISTAD) trial. J Am Coll Cardiol 34 (1999) 1711-1720
34. Grover G., Sleph P., and Dzwonczyk S. Role of myocardial ATP-sensitive potassium channels in mediating preconditioning in the dog heart and their possible interaction with adenosine A1-receptors. Circulation 86 (1992) 1310-1316
35. IONA Study Group. Effect of nicorandil on coronary events in patients with stable angina: the Impact Of Nicorandil in Angina (IONA) randomised trial. Lancet 359 (2002) 1269-1275